What is the current annual EBIT of NVS?

As of today, NVS annual EBIT is $16.47B

What is 1-year change in NVS annual EBIT?

NVS annual EBIT is up +6.81% year-over-year

What is 3-year change in NVS annual EBIT?

NVS annual EBIT is up +58.57% over the past 3 years

How far is NVS annual EBIT from its all-time high?

NVS annual EBIT is currently at its all-time high

How does NVS annual EBIT rank versus sector peers?

NVS annual EBIT is higher than 99.49% of companies in Healthcare sector

When is NVS next annual earnings release?

As of today, the next annual earnings release for NVS has not been scheduled

What is the current quarterly EBIT of NVS?

As of today, NVS quarterly EBIT is $3.76B

What is NVS quarterly EBIT most recent change?

NVS quarterly EBIT was up +6.68% on March 31, 2026

What is 1-year change in NVS quarterly EBIT?

NVS quarterly EBIT is down -18.05% year-over-year

How far is NVS quarterly EBIT from its all-time high?

NVS quarterly EBIT is currently -34.07% below its historical high of $5.70B set on March 31, 2000

How does NVS quarterly EBIT rank versus sector peers?

NVS quarterly EBIT is higher than 99.18% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on July 21, 2026

What is the current TTM EBIT of NVS?

As of today, NVS TTM EBIT is $16.23B

What is NVS TTM EBIT most recent change?

NVS TTM EBIT was down -4.85% on March 31, 2026

What is 1-year change in NVS TTM EBIT?

NVS TTM EBIT is down -0.65% year-over-year

How far is NVS TTM EBIT from its all-time high?

NVS TTM EBIT is currently -6.14% below its historical high of $17.29B set on September 29, 2025

How does NVS TTM EBIT rank versus sector peers?

NVS TTM EBIT is higher than 99.54% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on July 21, 2026

Novartis AG (NVS) EBIT History & Chart Since 1993

Annual EBIT

$16.47B$1.05B+6.81%

December 31, 2025

Summary

Current Value: As of today, NVS annual EBIT is $16.47B, up +6.81% on December 31, 2025
Historical Performance: NVS annual EBIT is up +58.57% over the past 3 years, up +52.22% over the past 5 years
All-Time High Comparison: NVS annual EBIT is currently at its all-time high
3-Year Low Comparison: NVS annual EBIT is +58.57% above its 3-year low of $10.39B reached on an earlier date
Sector Comparison: NVS annual EBIT is higher than 99.49% of companies in Healthcare sector

EBIT Chart

Performance

NVS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBIT	Dec 31, 25	$16.47B	+6.8%	+58.6%	+52.2%	+77.5%
Quarterly EBIT	Mar 31, 26	$3.76B	-18.1%	+33.5%	+36.4%	+23.7%
TTM EBIT	Mar 31, 26	$16.23B	-0.7%	+37.8%	+59.5%	+43.1%
Price	May 8, 26	$146.03	+32.6%	+39.2%	+66.0%	+172.1%
PE Ratio	May 8, 26	20.81	+20.5%	-35.4%	-17.7%	+66.0%
Annual Revenue	Dec 31, 25	$54.81B	+9.0%	+29.6%	+12.6%	+9.2%
Annual EPS	Dec 31, 25	$7.19	+22.6%	+126.7%	+104.5%	+70.1%
Annual EBITDA	Dec 31, 25	$21.82B	+1.6%	+27.6%	+37.0%	+85.6%
Annual Net Income	Dec 31, 25	$14.04B	+17.6%	+131.6%	+73.9%	+42.0%

EBIT Highs

NVS Annual EBIT Highs Comparison
Period	High	Date	Current
3Y	$16.47B	Dec 31, 25	at high
5Y	$16.47B	Dec 31, 25	at high
All	$16.47B	Dec 31, 25	at high

EBIT Lows

NVS Annual EBIT Lows Comparison
Period	Low	Date	Current
3Y	$10.39B	N/A	+58.6%
5Y	$10.39B	Dec 31, 22	+58.6%
All	$2.86B	Dec 1, 93	+475.6%

EBIT History

Year	Value	Change
2025	$16.47B	+6.8%
2024	$15.42B	+29.9%
2023	$11.87B	+14.3%
2022	$10.39B	-10.5%
2021	$11.60B	+7.2%
2020	$10.82B	+7.2%
2019	$10.09B	+13.9%
2018	$8.86B	-3.5%
2017	$9.19B	+10.2%
2016	$8.34B	-16.3%
2015	$9.95B	-21.7%
2014	$12.71B	+6.1%
2013	$11.99B	-1.6%
2012	$12.18B	+27.7%
2011	$9.54B	+2.8%
2010	$9.28B	+4.2%
2009	$8.90B	-9.4%

Year	Value	Change
2008	$9.83B	+31.5%
2007	$7.48B	-0.2%
2006	$7.49B	+8.9%
2005	$6.88B	+13.4%
2004	$6.07B	+1.4%
2003	$5.98B	+10.4%
2002	$5.42B	+25.7%
2001	$4.31B	-8.8%
2000	$4.73B	-5.4%
1999	$5.00B	-1.6%
1998	$5.08B	+8.6%
1997	$4.68B	+6.8%
1996	$4.38B	-5.9%
1995	$4.65B	+24.8%
1994	$3.73B	+30.3%
1993	$2.86B	-

FAQ

What is the current annual EBIT of NVS?
As of today, NVS annual EBIT is $16.47B
What is 1-year change in NVS annual EBIT?
NVS annual EBIT is up +6.81% year-over-year
What is 3-year change in NVS annual EBIT?
NVS annual EBIT is up +58.57% over the past 3 years
How far is NVS annual EBIT from its all-time high?
NVS annual EBIT is currently at its all-time high
How does NVS annual EBIT rank versus sector peers?
NVS annual EBIT is higher than 99.49% of companies in Healthcare sector
When is NVS next annual earnings release?
As of today, the next annual earnings release for NVS has not been scheduled

Quarterly EBIT

$3.76B$235.17M+6.68%

March 31, 2026

Summary

Current Value: As of today, NVS quarterly EBIT is $3.76B, up +6.68% on March 31, 2026
Historical Performance: NVS quarterly EBIT is down -18.05% year-over-year, up +33.49% over the past 3 years
All-Time High Comparison: NVS quarterly EBIT is currently -34.07% below its historical high of $5.70B set on March 31, 2000
3-Year Low Comparison: NVS quarterly EBIT is +39.20% above its 3-year low of $2.70B reached on June 30, 2023
Sector Comparison: NVS quarterly EBIT is higher than 99.18% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBIT	Mar 31, 26	$3.76B	+6.7%	-18.1%	+33.5%	+36.4%
Annual EBIT	Dec 31, 25	$16.47B	–	+6.8%	+58.6%	+52.2%
TTM EBIT	Mar 31, 26	$16.23B	-4.8%	-0.7%	+37.8%	+59.5%
Price	May 8, 26	$146.03	-6.6%	+32.6%	+39.2%	+66.0%
PE Ratio	May 8, 26	20.81	-4.4%	+20.5%	-35.4%	-17.7%
Quarterly Revenue	Mar 31, 26	$13.17B	-1.3%	-0.5%	+21.6%	+6.1%
Quarterly EPS	Mar 31, 26	$1.65	+32.4%	-9.2%	+52.5%	+81.9%
Quarterly EBITDA	Mar 31, 26	$4.95B	-2.4%	-13.7%	+5.6%	+11.2%
Quarterly Net Income	Mar 31, 26	$3.17B	+31.8%	-12.2%	+47.0%	+53.9%

Quarterly EBIT Highs

NVS Quarterly EBIT Highs Comparison
Period	High	Date	Current
1Y	$4.75B	Jun 30, 25	-21.0%
3Y	$4.75B	Jun 30, 25	-21.0%
5Y	$4.75B	Jun 30, 25	-21.0%
All	$5.70B	Mar 31, 00	-34.1%

Quarterly EBIT Lows

NVS Quarterly EBIT Lows Comparison
Period	Low	Date	Current
1Y	$3.52B	Dec 31, 25	+6.7%
3Y	$2.70B	Jun 30, 23	+39.2%
5Y	$2.13B	Sep 30, 22	+76.2%
All	$0.00	Dec 31, 00	N/A

Quarterly EBIT History

Month	Value	Change
Mar 2026	$3.76B	+6.7%
Dec 2025	$3.52B	-16.1%
Sep 2025	$4.20B	-11.7%
Jun 2025	$4.75B	+3.7%
Mar 2025	$4.58B	+22.1%
Dec 2024	$3.75B	-7.7%
Sep 2024	$4.07B	+3.5%
Jun 2024	$3.93B	+8.2%
Mar 2024	$3.63B	+31.0%
Dec 2023	$2.77B	-18.6%
Sep 2023	$3.41B	+26.2%
Jun 2023	$2.70B	-4.1%
Mar 2023	$2.81B	-21.4%
Dec 2022	$3.58B	+67.9%
Sep 2022	$2.13B	-34.5%
Jun 2022	$3.25B	+10.4%
Mar 2022	$2.95B	+2.7%
Dec 2021	$2.87B	-12.0%
Sep 2021	$3.26B	+6.1%
Jun 2021	$3.07B	+11.6%
Mar 2021	$2.75B	+19.3%
Dec 2020	$2.31B	-22.2%
Sep 2020	$2.97B	+38.3%
Jun 2020	$2.14B	-29.7%
Mar 2020	$3.05B	+75.2%
Dec 2019	$1.74B	-36.1%
Sep 2019	$2.72B	-0.2%
Jun 2019	$2.73B	+19.2%
Mar 2019	$2.29B	+43.8%
Dec 2018	$1.59B	-28.8%
Sep 2018	$2.24B	+2.3%
Jun 2018	$2.18B	-1.8%
Mar 2018	$2.23B	+4.4%
Dec 2017	$2.13B	-13.1%
Sep 2017	$2.45B	+3.5%
Jun 2017	$2.37B	+16.1%
Mar 2017	$2.04B	+20.3%
Dec 2016	$1.70B	-27.8%
Sep 2016	$2.35B	-1.7%
Jun 2016	$2.39B	+6.1%
Mar 2016	$2.25B	+18.7%
Dec 2015	$1.90B	-22.3%
Sep 2015	$2.44B	-5.5%
Jun 2015	$2.59B	-10.0%
Mar 2015	$2.87B	+17.9%
Dec 2014	$2.44B	-21.5%
Sep 2014	$3.11B	-14.6%
Jun 2014	$3.64B	+23.8%
Mar 2014	$2.94B	+14.3%
Dec 2013	$2.57B	-11.1%
Sep 2013	$2.89B	-8.6%
Jun 2013	$3.16B	+23.1%
Mar 2013	$2.57B	+34.0%

Month	Value	Change
Dec 2012	$1.92B	-19.0%
Sep 2012	$2.37B	-4.8%
Jun 2012	$2.49B	+18.8%
Mar 2012	$2.09B	+115.0%
Dec 2011	$973.07M	-64.7%
Sep 2011	$2.75B	-2.2%
Jun 2011	$2.81B	-7.3%
Mar 2011	$3.04B	+17.6%
Dec 2010	$2.58B	-17.4%
Sep 2010	$3.13B	+20.7%
Jun 2010	$2.59B	-19.7%
Mar 2010	$3.23B	+3.6%
Dec 2009	$3.12B	+14.1%
Sep 2009	$2.73B	+14.3%
Jun 2009	$2.39B	+8.4%
Mar 2009	$2.20B	+27.7%
Dec 2008	$1.73B	-28.3%
Sep 2008	$2.41B	+1.8%
Jun 2008	$2.37B	+8.1%
Mar 2008	$2.19B	+233.0%
Dec 2007	$657.00M	-70.9%
Sep 2007	$2.26B	+15.5%
Jun 2007	$1.95B	-12.6%
Mar 2007	$2.24B	+52.3%
Dec 2006	$1.47B	-26.8%
Sep 2006	$2.01B	+0.4%
Jun 2006	$2.00B	-1.4%
Mar 2006	$2.03B	+35.3%
Dec 2005	$1.50B	-27.6%
Sep 2005	$2.07B	+14.7%
Jun 2005	$1.80B	+22.2%
Mar 2005	$1.47B	+3.9%
Dec 2004	$1.42B	-9.9%
Sep 2004	$1.57B	-12.2%
Jun 2004	$1.79B	+15.0%
Mar 2004	$1.56B	-5.0%
Dec 2003	$1.64B	+11.7%
Sep 2003	$1.47B	-4.3%
Jun 2003	$1.54B	+6.6%
Mar 2003	$1.44B	+7.4%
Dec 2002	$1.34B	+1.8%
Sep 2002	$1.32B	-1.4%
Jun 2002	$1.34B	+23.4%
Mar 2002	$1.08B	>+9,900.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	0.0%
Jun 2001	$0.00	0.0%
Mar 2001	$0.00	0.0%
Dec 2000	$0.00	-100.0%
Sep 2000	$4.88B	+388.1%
Jun 2000	$1.00B	-82.4%
Mar 2000	$5.70B	-

FAQ

What is the current quarterly EBIT of NVS?
As of today, NVS quarterly EBIT is $3.76B
What is NVS quarterly EBIT most recent change?
NVS quarterly EBIT was up +6.68% on March 31, 2026
What is 1-year change in NVS quarterly EBIT?
NVS quarterly EBIT is down -18.05% year-over-year
How far is NVS quarterly EBIT from its all-time high?
NVS quarterly EBIT is currently -34.07% below its historical high of $5.70B set on March 31, 2000
How does NVS quarterly EBIT rank versus sector peers?
NVS quarterly EBIT is higher than 99.18% of companies in Healthcare sector
When is NVS next earnings release?
The next earnings release for NVS is on July 21, 2026

TTM EBIT

$16.23B$827.10M-4.85%

March 31, 2026

Summary

Current Value: As of today, NVS TTM EBIT is $16.23B, down -4.85% on March 31, 2026
Historical Performance: NVS TTM EBIT is down -0.65% year-over-year, up +37.79% over the past 3 years
All-Time High Comparison: NVS TTM EBIT is currently -6.14% below its historical high of $17.29B set on September 29, 2025
3-Year Low Comparison: NVS TTM EBIT is +44.60% above its 3-year low of $11.22B reached on June 30, 2023
Sector Comparison: NVS TTM EBIT is higher than 99.54% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBIT	Mar 31, 26	$16.23B	-4.8%	-0.7%	+37.8%	+59.5%
Annual EBIT	Dec 31, 25	$16.47B	–	+6.8%	+58.6%	+52.2%
Quarterly EBIT	Mar 31, 26	$3.76B	+6.7%	-18.1%	+33.5%	+36.4%
Price	May 8, 26	$146.03	-6.6%	+32.6%	+39.2%	+66.0%
PE Ratio	May 8, 26	20.81	-4.4%	+20.5%	-35.4%	-17.7%
TTM Revenue	Mar 31, 26	$54.66B	-0.1%	+5.9%	+22.3%	+12.0%
TTM EPS	Mar 31, 26	$7.02	-2.3%	+10.0%	+115.6%	+101.8%
TTM EBITDA	Mar 31, 26	$21.41B	-3.5%	-3.7%	+11.5%	+26.5%
TTM Net Income	Mar 31, 26	$13.58B	-3.1%	+5.8%	+109.0%	+70.7%

TTM EBIT Highs

NVS TTM EBIT Highs Comparison
Period	High	Date	Current
1Y	$17.29B	Sep 29, 25	-6.1%
3Y	$17.29B	Sep 29, 25	-6.1%
5Y	$17.29B	Sep 29, 25	-6.1%
All	$17.29B	Sep 29, 25	-6.1%

TTM EBIT Lows

NVS TTM EBIT Lows Comparison
Period	Low	Date	Current
1Y	$16.23B	Mar 31, 26	at low
3Y	$11.22B	Jun 30, 23	+44.6%
5Y	$10.17B	N/A	+59.5%
All	$0.00	Sep 30, 01	N/A

TTM EBIT History

Month	Value	Change
Mar 2026	$16.23B	-4.9%
Dec 2025	$17.05B	-1.4%
Sep 2025	$17.29B	+0.8%
Jun 2025	$17.16B	+5.1%
Mar 2025	$16.33B	+6.2%
Dec 2024	$15.38B	+6.8%
Sep 2024	$14.40B	+4.8%
Jun 2024	$13.73B	+9.8%
Mar 2024	$12.50B	+7.0%
Dec 2023	$11.69B	-6.5%
Sep 2023	$12.50B	+11.4%
Jun 2023	$11.22B	-4.7%
Mar 2023	$11.78B	-1.1%
Dec 2022	$11.91B	+6.3%
Sep 2022	$11.20B	-9.2%
Jun 2022	$12.33B	+1.5%
Mar 2022	$12.15B	+1.6%
Dec 2021	$11.96B	+4.9%
Sep 2021	$11.39B	+2.7%
Jun 2021	$11.10B	+9.1%
Mar 2021	$10.17B	-2.8%
Dec 2020	$10.47B	+5.7%
Sep 2020	$9.90B	+2.5%
Jun 2020	$9.66B	-5.7%
Mar 2020	$10.24B	+8.0%
Dec 2019	$9.48B	+1.6%
Sep 2019	$9.33B	+5.5%
Jun 2019	$8.84B	+6.6%
Mar 2019	$8.30B	+0.8%
Dec 2018	$8.24B	-6.2%
Sep 2018	$8.78B	-2.4%
Jun 2018	$8.99B	-2.0%
Mar 2018	$9.18B	+2.1%
Dec 2017	$8.99B	+5.1%
Sep 2017	$8.55B	+1.2%
Jun 2017	$8.45B	-0.2%
Mar 2017	$8.47B	-2.5%
Dec 2016	$8.69B	-2.3%
Sep 2016	$8.89B	-1.1%
Jun 2016	$8.98B	-2.1%
Mar 2016	$9.18B	-6.3%
Dec 2015	$9.80B	-5.2%
Sep 2015	$10.34B	-6.0%
Jun 2015	$11.00B	-8.7%
Mar 2015	$12.05B	-0.5%
Dec 2014	$12.11B	-1.1%
Sep 2014	$12.24B	+1.8%
Jun 2014	$12.03B	+4.1%
Mar 2014	$11.56B	+3.3%
Dec 2013	$11.19B	+6.2%
Sep 2013	$10.54B	+5.2%
Jun 2013	$10.01B	+7.2%
Mar 2013	$9.34B	+5.4%

Month	Value	Change
Dec 2012	$8.86B	+11.9%
Sep 2012	$7.92B	-4.7%
Jun 2012	$8.30B	-3.8%
Mar 2012	$8.63B	-9.9%
Dec 2011	$9.58B	-14.4%
Sep 2011	$11.19B	-3.2%
Jun 2011	$11.56B	+2.0%
Mar 2011	$11.34B	-1.6%
Dec 2010	$11.53B	-4.4%
Sep 2010	$12.06B	+3.4%
Jun 2010	$11.67B	+1.8%
Mar 2010	$11.46B	+9.8%
Dec 2009	$10.44B	+15.4%
Sep 2009	$9.05B	+3.7%
Jun 2009	$8.73B	+0.3%
Mar 2009	$8.70B	+0.2%
Dec 2008	$8.69B	+14.0%
Sep 2008	$7.62B	+2.0%
Jun 2008	$7.47B	+5.8%
Mar 2008	$7.06B	-0.7%
Dec 2007	$7.11B	-10.3%
Sep 2007	$7.92B	+3.3%
Jun 2007	$7.67B	-0.6%
Mar 2007	$7.71B	+2.8%
Dec 2006	$7.50B	-0.4%
Sep 2006	$7.53B	-0.8%
Jun 2006	$7.59B	+2.7%
Mar 2006	$7.39B	+8.1%
Dec 2005	$6.84B	+1.1%
Sep 2005	$6.76B	+7.9%
Jun 2005	$6.27B	+0.1%
Mar 2005	$6.26B	-1.4%
Dec 2004	$6.35B	-3.4%
Sep 2004	$6.57B	+1.6%
Jun 2004	$6.47B	+4.1%
Mar 2004	$6.21B	+2.0%
Dec 2003	$6.09B	+5.2%
Sep 2003	$5.79B	+2.7%
Jun 2003	$5.64B	+3.6%
Mar 2003	$5.44B	+7.0%
Dec 2002	$5.08B	+35.9%
Sep 2002	$3.74B	+54.4%
Jun 2002	$2.42B	+123.4%
Mar 2002	$1.08B	>+9,900.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	-100.0%
Jun 2001	$4.88B	-17.0%
Mar 2001	$5.88B	-49.2%
Dec 2000	$11.58B	0.0%
Sep 2000	$11.58B	+72.9%
Jun 2000	$6.70B	+17.6%
Mar 2000	$5.70B	-

FAQ

What is the current TTM EBIT of NVS?
As of today, NVS TTM EBIT is $16.23B
What is NVS TTM EBIT most recent change?
NVS TTM EBIT was down -4.85% on March 31, 2026
What is 1-year change in NVS TTM EBIT?
NVS TTM EBIT is down -0.65% year-over-year
How far is NVS TTM EBIT from its all-time high?
NVS TTM EBIT is currently -6.14% below its historical high of $17.29B set on September 29, 2025
How does NVS TTM EBIT rank versus sector peers?
NVS TTM EBIT is higher than 99.54% of companies in Healthcare sector
When is NVS next earnings release?
The next earnings release for NVS is on July 21, 2026

EBIT Formula

EBIT = Revenue − Cost Of Goods Sold − Operating Expenses

Data Sources & References

NVS Official Website www.novartis.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs